,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny04']
the presentation of destiny04 made the b1 hall electrifying #asco22 new era for patients, but still ild seen in 8% of pts 
Proud to be Puerto Rican, mother, wife and oncologist, representing community oncologist @ASCO BOD 21-25, @TheStartcenterforcancercare. Opinions are my own.